238.35
+7.50
+(3.25%)
At close: March 3 at 4:21:29 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 22 | 21 |
| Avg. Estimate | 4.02B | 4.51B | 18.06B | 19.93B |
| Low Estimate | 3.97B | 4.43B | 17.8B | 19.6B |
| High Estimate | 4.15B | 4.59B | 19.4B | 20.82B |
| Year Ago Sales | 3.73B | 4.11B | 16.48B | 18.06B |
| Sales Growth (year/est) | 7.71% | 9.76% | 9.59% | 10.32% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RC8.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Maintains | Tigress Financial: Buy to Buy | 2/7/2025 |
| Initiated | Loop Capital: Hold | 2/4/2025 |
| Maintains | UBS: Buy to Buy | 2/4/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/3/2025 |
| Maintains | Macquarie: Outperform to Outperform | 1/30/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 1/29/2025 |